Frankfurt
02.04.26 | 08:33
0,004 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,005 | 0,006 | 02.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Verici Dx PLC - Board Change | - | RNS | ||
| Mo | Verici Dx PLC - Holding(s) in Company | 1 | RNS | ||
| 05.02. | Verici Dx reports $3.8m revenue for FY25, driven by Tutivia test sales | 2 | Investing.com | ||
| 05.02. | Verici Dx PLC - FY25 Trading Update | - | RNS | ||
| 05.02. | Verici Dx PLC - Agreement with BCBS of Illinois for Tutivia | - | RNS | ||
| 12.11.25 | Verici Dx PLC - Completion of CAP accreditation audit | - | RNS | ||
| 06.11.25 | Verici Dx PLC - Provider Participation Agreement with Prime Health | - | RNS | ||
| VERICI DX Aktie jetzt für 0€ handeln | |||||
| 03.11.25 | TRADING UPDATES: Northcoders contract wins; Verici Dx completes audit | 1 | Alliance News | ||
| 03.11.25 | Verici Dx PLC - Completion of ISO 27001 surveillance audit | - | RNS | ||
| 30.10.25 | Verici Dx revises option pricing, grants new share options | 2 | Investing.com | ||
| 30.10.25 | Verici Dx PLC - Options revision & Grant of new share options | - | RNS | ||
| 06.10.25 | IN BRIEF: Verici Dx shares jump as posts progress on Tutivia adoption | 2 | Alliance News | ||
| 06.10.25 | Verici Dx PLC - Board Changes | - | RNS | ||
| 06.10.25 | Verici Dx PLC - Update on Tutivia test adoption | - | RNS |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDIGENE | 0,024 | -22,93 % | Medigene: Zurückziehung - 18.11.2025 | ||
| CO.DON | 0,022 | +22,22 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| TME PHARMA | 0,071 | 0,00 % | TME Pharma NV: TME Pharma extends financial runway to over 12 months | TME Pharma extends financial runway to over 12 months Berlin, Germany, March 9, 2025, 08.00am CET - TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing... ► Artikel lesen | |
| REPLENISH NUTRIENTS | 0,077 | 0,00 % | Replenish Nutrients Holding Corp: Replenish closes final tranche of private placement | ||
| GLOW LIFETECH | 0,027 | +5,88 % | Glow Lifetech Corp.: Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired | Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding... ► Artikel lesen | |
| ADAPTIMMUNE THERAPEUTICS | 0,007 | -38,10 % | Adaptimmune Therapeutics PLC: Adaptimmune Announces Changes to Board and Executive Leadership Team | Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - November 17, 2025) - Adaptimmune Therapeutics plc (OTC Pink: ADAPY) ("Adaptimmune" or the "Company") today announced changes... ► Artikel lesen | |
| BIOVAXYS TECHNOLOGY | 0,031 | -8,96 % | BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | ||
| TELO GENOMICS | 0,023 | 0,00 % | Telo Genomics Corp.: Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman | Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and... ► Artikel lesen | |
| ALTERITY THERAPEUTICS | 0,005 | 0,00 % | ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program | MELBOURNE, Australia and SAN FRANCISCO, March 30, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing... ► Artikel lesen | |
| MEDMIRA | 0,035 | -12,66 % | MedMira, Inc.: MedMira Reports Second Quarter Results FY2025 | HALIFAX, NS / ACCESS Newswire / April 1, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026.Corporate updateIn Q2 FY2026, the Company... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025 | ||
| BIOPHYTIS | 0,000 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.12.2025 | Das Instrument 6XB3 FR001400OLP5 BIOPHYTIS NAM. EO -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 09.12.2025 und ex Kapitalmassnahme am 10.12.2025 The instrument 6XB3 FR001400OLP5 BIOPHYTIS NAM.... ► Artikel lesen | |
| ACTIVE BIOTECH | 0,006 | -12,86 % | Active Biotech AB: Active Biotech Year End Report 2025 | FOURTH QUARTER IN BRIEFActive Biotech announced a fully secured rights issue, subject to approval by an extraordinary general meeting, of approximately SEK 70 million before transaction costs (October... ► Artikel lesen | |
| ALGORAE PHARMACEUTICALS | 0,008 | 0,00 % | ALGORAE PHARMACEUTICALS LIMITED: Proposed issue of securities - 1AI |
VERICI DX PLC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VERICI DX PLC finden Sie auf Wallstreet Online.